Publications by authors named "Aleksandra Rachitskaya"

To investigate how home optical coherence tomography (OCT) influences the clinical decision-making of retina specialists for the management of neovascular age-related macular degeneration (nAMD). In this retrospective imaging review, 15 retina specialists each evaluated 10 home OCT data segments from 29 eyes being treated for nAMD. Based on OCT data, indications were identified for when eyes should be treated, which antivascular endothelial growth factor should be used, and the specific retinal fluid and time thresholds for notification.

View Article and Find Full Text PDF
Article Synopsis
  • The study examined children aged 3-18 with low vision at an eye center, focusing on their demographics, surgical history, and health determinants from 2014 to 2019.
  • Out of over 47,000 children assessed, 882 had low vision, with common causes including refractive/strabismic amblyopia and retinal diseases; many required surgical interventions.
  • Results showed a strong link between the severity of vision loss and the number of surgeries, while no significant relationship was found between patients' income or insurance and their visual outcomes or need for surgery.*
View Article and Find Full Text PDF

Purpose: To discuss the worldwide applications and potential impact of artificial intelligence (AI) for the diagnosis, management and analysis of treatment outcomes of common retinal diseases.

Methods: We performed an online literature review, using PubMed Central (PMC), of AI applications to evaluate and manage retinal diseases. Search terms included AI for screening, diagnosis, monitoring, management, and treatment outcomes for age-related macular degeneration (AMD), diabetic retinopathy (DR), retinal surgery, retinal vascular disease, retinopathy of prematurity (ROP) and sickle cell retinopathy (SCR).

View Article and Find Full Text PDF

Objective: The potential association between diabetic retinopathy (DR) worsening and glucagon-like peptide-1 receptor agonists (GLP-1RA) has affected therapeutic management of diabetic patients but remains controversial. This study compared rates of DR development or progression in patients on GLP-1RA to those on SGLT-2 inhibitors (SGLT-2I).

Design: Retrospective cohort study.

View Article and Find Full Text PDF
Article Synopsis
  • Vision loss is a significant disability in the US, and this study aimed to understand the impact of various ocular diseases, demographic factors like sex and race, on the risk of visual impairment.
  • The analysis utilized data from over 90 million patients, focusing on conditions such as diabetic retinopathy, macular degeneration, and glaucoma, identifying those most at risk based on comorbidities and demographics.
  • Results showed that uveitis combined with retinal vein occlusion posed the highest risk for visual impairment, with Black and Hispanic males experiencing a disproportionate incidence compared to white males.
View Article and Find Full Text PDF

Purpose: Complications associated with intravitreal anti-VEGF therapies are reported inconsistently in the literature, thus limiting an accurate evaluation and comparison of safety between studies. This study aimed to develop a standardized classification system for anti-VEGF ocular complications using the Delphi consensus process.

Design: Systematic review and Delphi consensus process.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to analyze the visual results and closure rates of macular holes associated with tractional retinal detachment and proliferative diabetic retinopathy by reviewing patient data after vitrectomy.
  • - A total of ten patients with tractional retinal detachment-related macular holes were followed, with a 90% closure rate observed at 3 months and all holes closed by 12 months, except for one eye that required a reoperation.
  • - Visual acuity improved from a baseline of 20/235 to 20/138 after one year, indicating that while the macular holes presented with various forms due to proliferative diabetic retinopathy, there was a significant rate of closure and potential for improved vision.
View Article and Find Full Text PDF
Article Synopsis
  • - The GATHER trials aimed to assess how reducing geographic atrophy (GA) lesion growth affects visual acuity, using randomized, double-masked, and sham-controlled methods with participants aged 50 or older.
  • - In these trials, patients were randomized to receive either 2 mg of avacincaptad pegol (ACP) or a sham treatment, with results showing a lower percentage of vision loss in those treated with ACP at 12 months compared to the sham group.
  • - The study concluded that ACP 2 mg treatment effectively delayed the progression of vision loss and maintained eligibility for driving in patients compared to those receiving sham treatment.
View Article and Find Full Text PDF

Background And Objective: This study compared the surgeon experience between conventional microscope-integrated intraoperative optical coherence tomography (iOCT) and digitally enabled microscope-integrated iOCT in vitreoretinal surgery.

Patients And Methods: This is a post hoc case-control analysis of the DISCOVER study. Conventional microscope-integrated iOCT (Rescan 700, Zeiss) was compared with digitally enabled iOCT (Artevo 800, Zeiss).

View Article and Find Full Text PDF

Advances in the care of premature infants have resulted in unprecedented rates of survival of these infants into adulthood, including those born at very low gestational ages. Ophthalmologists have historically followed premature infants to assess for the presence of and potential need for treatment of retinopathy of prematurity. However, a growing body of literature suggests that the ophthalmic consequences of prematurity extended beyond retinopathy of prematurity and that ophthalmic sequelae of prematurity can endure through adulthood even among formerly preterm adults who were never diagnosed with retinopathy of prematurity.

View Article and Find Full Text PDF

Background And Objective: Geographic atrophy (GA) is a form of late-stage age-related macular degeneration (AMD). This study aims to characterize the journey of patients with GA in real-world ophthalmology practice.

Patients And Methods: This is a retrospective cohort study of 100 patients with GA and 100 with intermediate AMD (iAMD).

View Article and Find Full Text PDF

To evaluate the effect of syringe type on developing sustained intraocular pressure (IOP) increases. This retrospective cohort study included patients in a single academic center receiving antivascular endothelial growth factor (anti-VEGF) injections from 2012 to 2022 for various indications. Patients were grouped by anti-VEGF treatment of either vial-drawn or prefilled syringe delivery.

View Article and Find Full Text PDF

Purpose: A subset of patients with neovascular age-related macular degeneration (nAMD) experience treatment burden and suboptimal response with anti-VEGF therapy. The aim of this study was to investigate the effect of switching to a novel, bispecific agent, faricimab, in patients with nAMD currently treated with anti-VEGF.

Design: Retrospective, noncomparative cohort study.

View Article and Find Full Text PDF

Importance: Language-learning model-based artificial intelligence (AI) chatbots are growing in popularity and have significant implications for both patient education and academia. Drawbacks of using AI chatbots in generating scientific abstracts and reference lists, including inaccurate content coming from hallucinations (ie, AI-generated output that deviates from its training data), have not been fully explored.

Objective: To evaluate and compare the quality of ophthalmic scientific abstracts and references generated by earlier and updated versions of a popular AI chatbot.

View Article and Find Full Text PDF

To assess the short-term and long-term effects of a delay in care on visual acuity (VA) in patients requiring intravitreal injections. This retrospective cohort study comprised patients with neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), or retinal vein occlusion (RVO) receiving intravitreal injections. The visual and anatomic outcomes at the next completed visit and at the 1-year follow-up were studied.

View Article and Find Full Text PDF

Background: Intravitreal injections of anti-vascular endothelial growth factor (anti-VEGF) are first-line therapy for macular oedema in retinal vein occlusion (RVO). Appropriate management for RVO with good visual acuity at diagnosis has not been evaluated. The purpose of this study is to analyse the visual and anatomic outcomes from anti-VEGF treatment among RVO patients with good vision at baseline.

View Article and Find Full Text PDF

Purpose Of Review: Age-related macular degeneration (AMD) is one of the leading causes of blindness and can progress to geographic atrophy (GA) in late stages of disease. This review article highlights recent literature which assists in the accurate and timely identification of GA, and monitoring of GA progression.

Recent Findings: Technology for diagnosing and monitoring GA has made significant advances in recent years, particularly regarding the use of optical coherence tomography (OCT).

View Article and Find Full Text PDF

Purpose: To assess the awareness of biosimilar intravitreal anti-VEGF agents among retina specialists practicing in the United States (US) and Europe.

Methods: A 16-question online survey was created in English and distributed between Dec 01, 2021 and Jan 31, 2022. A total of 112 respondents (retinal physicians) from the US and Europe participated.

View Article and Find Full Text PDF

Purpose: To evaluate the anatomic and visual outcomes of patients with idiopathic epiretinal membranes (ERMs) complicated by schisis of the retinal nerve fiber layer (sRNFL) in routine clinical practice.

Design: Retrospective case-control study.

Participants: Patients undergoing idiopathic ERM surgery at Cole Eye Institute from 2013 to 2021.

View Article and Find Full Text PDF